Cassava Sciences (SAVA) Revenue & Revenue Breakdown
Cassava Sciences Revenue Highlights
00
Cassava Sciences Revenue by Period
Cassava Sciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | -100.00% |
2013-12-31 | - | 277.58% |
2012-12-31 | - | -5.17% |
2011-12-31 | - | -31.68% |
2010-12-31 | - | -18.26% |
2009-12-31 | - | -67.73% |
2008-12-31 | - | -3.42% |
2007-12-31 | - | 22.38% |
2006-12-31 | - | 961.38% |
2005-12-31 | - | 100.00% |
2004-12-31 | - | 100.00% |
2003-12-31 | - | -100.00% |
2002-12-31 | - | 100.00% |
2001-12-31 | - | -100.00% |
2000-12-31 | - | - |
1999-12-31 | - | - |
Cassava Sciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | - | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | -100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | -100.00% |
2013-12-31 | - | 1700.00% |
2013-09-30 | - | -0.05% |
2013-06-30 | - | 0.05% |
2013-03-31 | - | -20.66% |
2012-12-31 | - | -9.43% |
2012-09-30 | - | 0.04% |
2012-06-30 | - | -8.38% |
2012-03-31 | - | 8.23% |
2011-12-31 | - | -0.07% |
2011-09-30 | - | -0.11% |
2011-06-30 | - | -14.96% |
2011-03-31 | - | -59.60% |
2010-12-31 | - | 176.65% |
2010-09-30 | - | 9.00% |
2010-06-30 | - | -18.25% |
2010-03-31 | - | -12.87% |
2009-12-31 | - | -0.90% |
2009-09-30 | - | -39.66% |
2009-06-30 | - | -8.76% |
2009-03-31 | - | -17.09% |
2008-12-31 | - | -72.79% |
2008-09-30 | - | 187.23% |
2008-06-30 | - | -27.95% |
2008-03-31 | - | 4.15% |
2007-12-31 | - | -11.09% |
2007-09-30 | - | - |
Cassava Sciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EXEL | Exelixis | - | - |
AXSM | Axsome Therapeutics | - | - |
TGTX | TG Therapeutics | - | - |
MCRB | Seres Therapeutics | - | - |
VIR | Vir Bio | - | - |
CVAC | CureVac | - | - |
KRYS | Krystal Biotech | - | - |
BTAI | BioXcel Therapeutics | - | - |
VKTX | Viking Therapeutics | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
BIVI | BioVie | - | - |
SAVA | Cassava Sciences | - | - |
CGTX | Cognition Therapeutics | - | - |
MDGL | Madrigal Pharmaceuticals | - | - |
ANVS | Annovis Bio | - | - |
AVXL | Anavex Life Sciences | - | - |
INMB | INmune Bio | - | - |